Sight Diagnostics scoops up $71m Series D

Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.

5 August 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles